Takeda Pharmaceutical(us:TAK)
14.87
+0.95%
Updated on 2025-03-31
Open:14.79
Close:14.87
High:14.95
Low:14.75
Prev Close:14.73
Volume:1.77M
Turnover:26.21M
Turnover Ratio:0.06%
Shares:3.07B
MarketCap:45.65B
| Date | Total | Total Shares | Total Ratio | New | Increased | Decreased |
|---|---|---|---|---|---|---|
| 2024-06-30 | 336 | 72016321 | 2.29% | 27 | 90 | 158 |
| 2024-03-31 | 335 | 77892609 | 2.48% | 40 | 113 | 114 |
| 2023-12-31 | 350 | 83104983 | 2.65% | 52 | 63 | 173 |
| 2023-09-30 | 332 | 80171204 | 2.55% | 38 | 108 | 119 |
| 2023-06-30 | 331 | 83776866 | 2.69% | 39 | 91 | 124 |
| 2023-03-31 | 306 | 86356760 | 2.78% | 43 | 107 | 87 |
| 2022-12-31 | 311 | 67876622 | 2.18% | 52 | 70 | 139 |
| 2022-09-30 | 296 | 63645547 | 2.05% | 31 | 95 | 99 |
| date | orgName | total | ratio | changeShares | changeRatio |
|---|---|---|---|---|---|
| 2024-06-30 | Capital Research Global Investors | 13126608 | 0.42% | 4678 | 0.04% |
| 2024-06-30 | Mondrian Investment Partners Ltd | 7738748 | 0.25% | -4341214 | -35.94% |
| 2024-06-30 | Morgan Stanley | 4986952 | 0.16% | -8671 | -0.17% |
| 2024-06-30 | Millennium Management Llc | 4346151 | 0.14% | 2023707 | 87.14% |
| 2024-06-30 | Goldman Sachs Group Inc | 3717457 | 0.12% | -491974 | -11.69% |
| 2024-06-30 | Renaissance Technologies Llc | 2954800 | 0.09% | -163400 | -5.24% |
| 2024-06-30 | Brandes Investment Partners, Lp | 2635027 | 0.08% | -267480 | -9.21% |
| 2024-06-30 | Fmr Llc | 2622866 | 0.08% | 48626 | 1.89% |
| 2024-06-30 | Arrowstreet Capital, Limited Partnership | 2315515 | 0.07% | 950588 | 69.64% |
| 2024-06-30 | Van Eck Associates Corp | 2040829 | 0.07% | 356069 | 21.14% |
About
Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.
Address:4-1-1 Dosho-machi,Chuo-Ku
Market Movers